Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s): FENC

Healthcare Biotechnology

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.

TSX:FRX - Post by User

Fennec Pharmaceuticals Ord Shs

Bullboard Posts

Comment by commissionson Apr 27, 2004 2:34pm

169 Views

Post# 7408143

RE: raising cash ?

I would imagine that is exactly why he is there.A smooth transition onto the AMEX and then the launch onto the big board.The Nasdaq listing is of huge importance but so will be one last monster financing/IPO/reverse split that should give the company all the cash that they need before licencing agreements get signed with big pharma to carry the balance of costs. Don't forget STS as well which is going to bring in $100-125 US A YEAR STARTING IN 2007 ( PERHAPS SOONER? ).This is important because it should reduce what we have to give up on the licencing agreements.Mr. Klein I am sure from a shareholders perspective will earn his keep in spades. Commissions.

Bullboard Posts

Rich TV Live’s Stocks to Watch this week (Nov. 15, 2024)